These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 26264622)

  • 1. A novel pathway of cellular activation mediated by antiphospholipid antibody-induced extracellular vesicles.
    Wu M; Barnard J; Kundu S; McCrae KR
    J Thromb Haemost; 2015 Oct; 13(10):1928-40. PubMed ID: 26264622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiphospholipid-exposed trophoblast-derived extracellular vesicles express elevated levels of TLR7/8-activating microRNAs and induce endometrial endothelial activation, in part, through TLR7.
    Coenen CS; Hidalgo TN; Lynn T; Jones DM; Salmon JE; Chamley LW; Abrahams VM
    J Reprod Immunol; 2024 Aug; 164():104255. PubMed ID: 38797133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel pathway for human endothelial cell activation by antiphospholipid/anti-β2 glycoprotein I antibodies.
    Allen KL; Fonseca FV; Betapudi V; Willard B; Zhang J; McCrae KR
    Blood; 2012 Jan; 119(3):884-93. PubMed ID: 22106343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-β2GPI antibodies stimulate endothelial cell microparticle release via a nonmuscle myosin II motor protein-dependent pathway.
    Betapudi V; Lominadze G; Hsi L; Willard B; Wu M; McCrae KR
    Blood; 2013 Nov; 122(23):3808-17. PubMed ID: 23954892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiphospholipid antibody-induced miR-146a-3p drives trophoblast interleukin-8 secretion through activation of Toll-like receptor 8.
    Gysler SM; Mulla MJ; Guerra M; Brosens JJ; Salmon JE; Chamley LW; Abrahams VM
    Mol Hum Reprod; 2016 Jul; 22(7):465-74. PubMed ID: 27029214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies.
    Raschi E; Testoni C; Bosisio D; Borghi MO; Koike T; Mantovani A; Meroni PL
    Blood; 2003 May; 101(9):3495-500. PubMed ID: 12531807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β2-glycoprotein I and its antibodies involve in the pathogenesis of the antiphospholipid syndrome.
    Bai A
    Immunol Lett; 2017 Jun; 186():15-19. PubMed ID: 28347805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-Line, Non-Criterial Antiphospholipid Antibody Testing for the Diagnosis of Antiphospholipid Syndrome in Clinical Practice: A Combination of Anti-β
    Nakamura H; Oku K; Amengual O; Ohmura K; Fujieda Y; Kato M; Bohgaki T; Yasuda S; Atsumi T
    Arthritis Care Res (Hoboken); 2018 Apr; 70(4):627-634. PubMed ID: 28686816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SIV Infection Regulates Compartmentalization of Circulating Blood Plasma miRNAs within Extracellular Vesicles (EVs) and Extracellular Condensates (ECs) and Decreases EV-Associated miRNA-128.
    Kopcho S; McDew-White M; Naushad W; Mohan M; Okeoma CM
    Viruses; 2023 Feb; 15(3):. PubMed ID: 36992331
    [No Abstract]   [Full Text] [Related]  

  • 10. More about cellular signaling by antiphospholipid antibodies.
    Lackner KJ
    J Thromb Haemost; 2015 Oct; 13(10):1925-7. PubMed ID: 26302892
    [No Abstract]   [Full Text] [Related]  

  • 11. A role for uric acid and the Nalp3 inflammasome in antiphospholipid antibody-induced IL-1β production by human first trimester trophoblast.
    Mulla MJ; Salmon JE; Chamley LW; Brosens JJ; Boeras CM; Kavathas PB; Abrahams VM
    PLoS One; 2013; 8(6):e65237. PubMed ID: 23762324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Directional Endothelial Communication by Polarized Extracellular Vesicle Release.
    Raju S; Botts SR; Blaser MC; Abdul-Samad M; Prajapati K; Khosraviani N; Ho TWW; Breda LCD; Ching C; Galant NJ; Fiddes L; Wu R; Clift CL; Pham T; Lee WL; Singh SA; Aikawa E; Fish JE; Howe KL
    Circ Res; 2024 Feb; 134(3):269-289. PubMed ID: 38174557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-β
    Virachith S; Saito M; Watanabe Y; Inoue K; Hoshi O; Kubota T
    Clin Exp Immunol; 2019 Feb; 195(2):167-178. PubMed ID: 30368780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2 -glycoprotein i domain 1 and domain 4/5: ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndrome.
    Andreoli L; Chighizola CB; Nalli C; Gerosa M; Borghi MO; Pregnolato F; Grossi C; Zanola A; Allegri F; Norman GL; Mahler M; Meroni PL; Tincani A
    Arthritis Rheumatol; 2015 May; 67(8):2196-204. PubMed ID: 25939498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The avidity of anti-beta2-glycoprotein I antibodies in patients with or without antiphospholipid syndrome: a collaborative study in the frame of the European forum on antiphospholipid antibodies.
    Cucnik S; Kveder T; Ulcova-Gallova Z; Swadzba J; Musial J; Valesini G; Avcin T; Rozman B; Bozic B
    Lupus; 2011 Oct; 20(11):1166-71. PubMed ID: 21712304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered β
    Mobarrez F; Gunnarsson I; Svenungsson E
    J Thromb Haemost; 2017 Sep; 15(9):1799-1806. PubMed ID: 28667788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial cell activation by antiphospholipid antibodies is modulated by Kruppel-like transcription factors.
    Allen KL; Hamik A; Jain MK; McCrae KR
    Blood; 2011 Jun; 117(23):6383-91. PubMed ID: 21482710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiphospholipid Antibodies Inhibit Trophoblast Toll-Like Receptor and Inflammasome Negative Regulators.
    Mulla MJ; Weel IC; Potter JA; Gysler SM; Salmon JE; Peraçoli MTS; Rothlin CV; Chamley LW; Abrahams VM
    Arthritis Rheumatol; 2018 Jun; 70(6):891-902. PubMed ID: 29342502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue factor over-expression in platelets of patients with anti-phospholipid syndrome: induction role of anti-β2-GPI antibodies.
    Capozzi A; Manganelli V; Riitano G; Recalchi S; Truglia S; Alessandri C; Longo A; Garofalo T; Misasi R; Valesini G; Conti F; Sorice M
    Clin Exp Immunol; 2019 Apr; 196(1):59-66. PubMed ID: 30549270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-3R-alpha blockade inhibits tumor endothelial cell-derived extracellular vesicle (EV)-mediated vessel formation by targeting the β-catenin pathway.
    Lombardo G; Gili M; Grange C; Cavallari C; Dentelli P; Togliatto G; Taverna D; Camussi G; Brizzi MF
    Oncogene; 2018 Mar; 37(9):1175-1191. PubMed ID: 29238040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.